Safety, tolerability, and efficacy of uptitration of guideline-directed medical therapy for acute heart failure stratified by baseline risk

Back

HFA Premium Access

Safety, tolerability, and efficacy of uptitration of guideline-directed medical therapy for acute heart failure stratified by baseline risk

Session: Chronic heart failure - treatment 5

Topic: Pharmacotherapy

Speaker: Doctor A. Chang (San Francisco, US)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Doctor Alex Chang

Kaiser Permanente, San Francisco Medical Centre and Medical Offices, San Francisco (United States of America)

0 follower

6 more presentations in this session

Renin-angiotensin-aldosterone system inhibitor discontinuation and its impact on one-year mortality in heart failure patients with acute kidney injury: a propensity matched analysis

Speaker: Doctor D. Feldman (Newark, US)

Deformation Imaging by Strain in Chronic heart failure Over gliflozins: an Echocardiographic Register on Sodium-GLucose coTransporter-2 inhibitors (DISCOVER SGLT2i)

Speaker: Doctor A. Stefanini (Siena, IT)

Initial safety of targeted immune activation with the amyloid depleter ALXN2220

Speaker: Professor T. Damy (Creteil, FR)

Age-stratified and sex-stratified effect of angiotensin receptor-neprilysin inhibitor in heart failure with reduced ejection fraction-data from PARADE-HF: nationwide medication adherence study

Speaker: Doctor M. Kim (Seoul, KR)

Access

Abstract

Slides

Representation of frailty in contemporary trials of heart failure medications: a systematic review and dose-response meta-analysis

Speaker: Doctor D. Rodolico (Pisa, IT)

Access the full session

Chronic heart failure - treatment 5

Speakers: Doctor A. Chang, Doctor D. Feldman, Doctor A. Stefanini, Professor T. Damy, Doctor M. Kim...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources